Literature DB >> 29118766

The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5.

Anna Clementi1,2, Grazia Maria Virzì1,3, Alessandra Brocca1,3,4, Claudio Ronco1,3.   

Abstract

Lipopolysaccharide or endotoxin, the major cell wall component of gram-negative bacteria, plays a pivotal role in the pathogenesis of sepsis. It is able to activate the host defense system through the interaction with Toll-like receptor 4, thus triggering pro-inflammatory mechanisms. When the production of inflammatory mediators becomes uncontrolled and excessive, septic shock develops with multiple organ dysfunction, such as myocardial and renal impairment, which are hallmarks of cardiorenal syndrome type 5. In this review, we will analyze the role of endotoxin in the pathogenesis of sepsis, its effects on cardiac and renal interactions in the setting of cardiorenal syndrome type 5 and the possible use of extracorporeal therapies in this clinical condition.

Entities:  

Keywords:  Cardiorenal syndrome type 5; Endotoxin; Lipopolysaccharide

Year:  2017        PMID: 29118766      PMCID: PMC5662967          DOI: 10.1159/000475846

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  59 in total

Review 1.  New insight in LPS antagonist.

Authors:  A Ianaro; M Tersigni; F D'Acquisto
Journal:  Mini Rev Med Chem       Date:  2009-03       Impact factor: 3.862

2.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

3.  Renal effects of nitric oxide in endotoxemia.

Authors:  R I Cohen; A M Hassell; K Marzouk; C Marini; S F Liu; S M Scharf
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

4.  Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock.

Authors:  Milan Stengl; Frantisek Bartak; Roman Sykora; Jiri Chvojka; Jan Benes; Ales Krouzecky; Ivan Novak; Jitka Sviglerova; Jitka Kuncova; Martin Matejovic
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

5.  Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter.

Authors:  M Brenner; G L Schaer; D L Mallory; A F Suffredini; J E Parrillo
Journal:  Chest       Date:  1990-07       Impact factor: 9.410

6.  Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.

Authors:  Dinna N Cruz; Massimo Antonelli; Roberto Fumagalli; Francesca Foltran; Nicola Brienza; Abele Donati; Vincenzo Malcangi; Flavia Petrini; Giada Volta; Franco M Bobbio Pallavicini; Federica Rottoli; Francesco Giunta; Claudio Ronco
Journal:  JAMA       Date:  2009-06-17       Impact factor: 56.272

Review 7.  Lipopolysaccharide: Biosynthetic pathway and structure modification.

Authors:  Xiaoyuan Wang; Peter J Quinn
Journal:  Prog Lipid Res       Date:  2009-10-06       Impact factor: 16.195

8.  Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.

Authors:  Steven M Opal; Pierre-Francois Laterre; Bruno Francois; Steven P LaRosa; Derek C Angus; Jean-Paul Mira; Xavier Wittebole; Thierry Dugernier; Dominique Perrotin; Mark Tidswell; Luis Jauregui; Kenneth Krell; Jan Pachl; Takeshi Takahashi; Claus Peckelsen; Edward Cordasco; Chia-Sheng Chang; Sandra Oeyen; Naoki Aikawa; Tatsuya Maruyama; Roland Schein; Andre C Kalil; Marc Van Nuffelen; Melvyn Lynn; Daniel P Rossignol; Jogadish Gogate; Mary B Roberts; Janice L Wheeler; Jean-Louis Vincent
Journal:  JAMA       Date:  2013-03-20       Impact factor: 56.272

9.  MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.

Authors:  R Shimazu; S Akashi; H Ogata; Y Nagai; K Fukudome; K Miyake; M Kimoto
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

Review 10.  Renal blood flow in sepsis.

Authors:  Christoph Langenberg; Rinaldo Bellomo; Clive May; Li Wan; Moritoki Egi; Stanislao Morgera
Journal:  Crit Care       Date:  2005-05-24       Impact factor: 9.097

View more
  2 in total

1.  Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1.

Authors:  Grazia Maria Virzì; Andrea Breglia; Chiara Castellani; Ghada Ankawi; Chiara Bolin; Massimo de Cal; Vito Cianci; Annalisa Angelini; Giorgio Vescovo; Claudio Ronco
Journal:  J Nephrol       Date:  2019-04-20       Impact factor: 3.902

2.  Klotho downregulation contributes to myocardial damage of cardiorenal syndrome in sepsis.

Authors:  Fei Yan; Yue Feng; Jin Chen; Jing Yan
Journal:  Mol Med Rep       Date:  2020-05-22       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.